Malla transvaginal para el tratamiento del prolapso de órganos pelvianos: resultados a largo plazo
Contenido principal del artículo
Downloads
Detalles del artículo
Sección

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Food and Drug Administration. FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. Silver Spring (MD): FDA; 2011. Available at: http:// www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ ucm262435.htm. Accessed 29 Sep 2016.
Food and Drug Administration. FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm. Accessed 29 Sep 2016.
Clemons JL, Weinstein M, Guess MK, et al. Impact of the 2011 FDA transvaginal mesh safety update on AUGS members’ use of synthetic mesh and biologic grafts in pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg. 2013; 19:191-8. DOI: https://doi.org/10.1097/SPV.0b013e31829099c1
Murphy M, Holzberg A, van Raalte H, et al. Pelvic Surgeons Network. Time to rethink: an evidence-based response from pelvic surgeons to the FDA Safety Communication: “UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse.” Int Urogynecol J. 2012; 23:5-9. DOI: https://doi.org/10.1007/s00192-011-1581-2
Jacquetin B, Hinoul P, Gauld J, et al. Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 5-year prospective follow-up study. Int Urogynecol J. 2013; 24:1679-86. DOI: https://doi.org/10.1007/s00192-013-2080-4
Miller D, Lucente V, Babin E, et al. D. Prospective clinical assessment of the transvaginal mesh technique for treatment of pelvic organ prolapse-5-year results. Female Pelvic Med Reconstr Surg. 2011; 17:139-43. DOI: https://doi.org/10.1097/SPV.0b013e3182175da6
Heinonen P, Aaltonen R, Joronen K, et al., Long-term outcome after transvaginal mesh repair of pelvic organ prolapse. Int Urogynecol J. 2016; 27:1069-74. DOI: https://doi.org/10.1007/s00192-015-2939-7
Bump RC, Anders M, Kari B, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175:10-7. DOI: https://doi.org/10.1016/S0002-9378(96)70243-0
Barber MD, Brubaker L, Nygaard I, et al. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009; 114:600-9.10. Kim CM, Jeon MJ, Chung DJ, et al. Risk factors for pelvic organ prolapse. Int J Gynecol Obstet. 2007; 98(3):248-51 DOI: https://doi.org/10.1097/AOG.0b013e3181b2b1ae